Загрузка...
Nalfurafine Suppresses Pruritogen- and Touch-evoked Scratching Behavior in Models of Acute and Chronic Itch in Mice
The kappa-opioid agonist, nalfurafine, has been approved in Japan for treatment of itch in patients with chronic kidney disease. We presently investigated if systemic administration of nalfurafine inhibited ongoing or touch-evoked scratching behavior (alloknesis) following acute intradermal injectio...
Сохранить в:
| Опубликовано в: : | Acta Derm Venereol |
|---|---|
| Главные авторы: | , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2015
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5550099/ https://ncbi.nlm.nih.gov/pubmed/24890341 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2340/00015555-1879 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|